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ARTICLE

PHLPP regulates hexokinase 2-dependent glucose metabolism
in colon cancer cells
Xiaopeng Xiong1, Yang-An Wen1, Mihail I Mitov1, Mary C Oaks2, Shigeki Miyamoto3 and Tianyan Gao1,4
Increased glucose metabolism is considered as one of the most important metabolic alterations adapted by cancer cells in order to
generate energy as well as high levels of glycolytic intermediates to support rapid proliferation. PH domain leucine-rich repeat
protein phosphatase (PHLPP) belongs to a novel family of Ser/Thr protein phosphatases that function as tumor suppressors in
various types of human cancer. Here we determined the role of PHLPP in regulating glucose metabolism in colon cancer cells.
Knockdown of PHLPP increased the rate of glucose consumption and lactate production, whereas overexpression of PHLPP had the
opposite effect. Bioenergetic analysis using Seahorse Extracelluar Flux Analyzer revealed that silencing PHLPP expression induced a
glycolytic shift in colon cancer cells. Mechanistically, we found that PHLPP formed a complex with Akt and hexokinase 2 (HK2) in
the mitochondrial fraction of colon cancer cells and knockdown of PHLPP enhanced Akt-mediated phosphorylation and
mitochondrial localization of HK2. Depletion of HK2 expression or treating cells with Akt and HK2 inhibitors reversed PHLPP lossinduced increase in glycolysis. Furthermore, PHLPP knockdown cells became addicted to glucose as a major energy source in that
glucose starvation signiﬁcantly decreased cancer cell survival. As HK2 is the key enzyme that determines the direction and
magnitude of glucose ﬂux, our study identiﬁed PHLPP as a novel regulator of glucose metabolism by controlling HK2 activity in
colon cancer cells.
Cell Death Discovery (2017) 3, 16103; doi:10.1038/cddiscovery.2016.103; published online 23 January 2017

INTRODUCTION
Deregulation of cell proliferation in cancer often requires
corresponding modiﬁcations in the cellular metabolism in order
to fuel the increasing need for the biosynthesis of macromolecules
including nucleotides, proteins and lipids.1–3 Glucose is one of the
major carbon sources for many types of cancers. To adapt to the
increased demand for the production of energy and metabolic
intermediates, cancer cells often upregulate aerobic glycolysis,4–6
a phenomenon that was ﬁrst described by Otto Warburg in
1920s.7 Clinically, the increased glycolytic phenotype associated
with cancer cells enables the detection of tumor lesions by FDGPET imaging.8 In addition, accumulating evidence has suggested
that mitochondrial metabolism is also essential for tumor growth
and progression. It has been shown that the mitochondrial
function is tightly coupled with increased glucose metabolism in
order to produce metabolites not only as building blocks for cell
proliferation but also as signaling molecules to control cell
signaling (Danvers, MA, USA).9,10 For example, Tan et al.11 reported
recently that cancer cells with defected mitochondria show
delayed tumor growth in primary lesion and impaired metastatic
potential.
Hexokinase (HK) catalyzes the ﬁrst step of glucose metabolism
that is phosphorylating glucose to glucose-6-phosphatase.12 There
are four isoforms, HK1, 2, 3 and 4, in the mammalian HK family.
In addition to their ability to control glycolysis, HK1 and HK2
can associate with mitochondria where they interact with porelike outer mitochondrial membrane protein voltage-dependent
anion channel to regulate apoptosis process.13,14 HK1 is ubiquitously expressed in most human tissues, whereas HK2 is the

predominant isoform expressed in insulin-sensitive tissues.15
Recent studies have shown that overexpression of HK2 promotes
cell proliferation and inhibits apoptosis in multiple cancer types
including brain, breast, lung, prostate and ovarian cancer.16–20
Furthermore, knockout of HK2 inhibits tumor initiation and
progression in KRAS-driven lung cancer and ErbB2-driven breast
cancer mouse models.21 Interestingly, it has been demonstrated
that HK2 is phosphorylated by Akt.22 This phosphorylation
promotes the mitochondrial localization of HK2 to protect
cardiomyocytes from metabolic stress-induced apoptosis.15,22
However, the functional importance of HK2-mediated glycolysis
in colon cancer remains elusive.
PHLPP (PH domain leucine-rich repeat protein phosphatase)
belongs to a novel family of Ser/Thr protein phosphatases. There
are two isoforms, PHLPP1 and PHLPP2, identiﬁed in this family.
Serving as negative regulators of several oncogenic protein
kinases, including Akt, S6K and RAF1, both PHLPP isoforms
function as tumor suppressors by maintaining the balance of cell
signaling and homeostasis.23–28 Previous studies have shown that
loss of PHLPP expression occurs frequently in colon cancer
patients26,29 and PHLPP loss promotes cell growth and survival
in vitro and tumorigenesis in vivo.24–26,29,30 In this study, we
investigated the role of PHLPP in modulating glucose metabolism
in colon cancer. Our results show that PHLPP negatively regulates
glycolysis by inhibiting Akt-dependent phosphorylation and
mitochondrial translocation of HK2. Consequently, loss of PHLPP
alters mitochondrial respiration and renders cells rely on glucose
metabolism for survival.
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RESULTS
Knockdown of PHLPP increases glucose metabolism in colon
cancer cells
Given the functional connection between Akt and glucose
metabolism, and our previous ﬁndings that PHLPP directly
dephosphorylates and inactivates Akt, we determined if loss of
PHLPP expression affects glucose utilization in colon cancer cells.
Stable control and PHLPP knockdown cells were cultured in
regular growth medium and the levels of glucose consumption
and lactate production were measured. Consistent with previous
reports, knockdown of either PHLPP isoform resulted in an
increase in Akt phosphorylation (Figure 1a). In addition, we found
that both glucose consumption and lactate production were
signiﬁcantly increased in multiple PHLPP knockdown colon cancer
cell lines suggesting enhanced glycolysis (Figures 1b and c).
To further evaluate the glycolytic phenotype, control and PHLPP
knockdown cells were subjected to Seahorse Extracellular Flux

analysis to assess the cellular bioenergetic activity. Results from
Seahorse glucose stress tests indicated that PHLPP loss signiﬁcantly increased the extracellular acidiﬁcation rate (ECAR)
associated with both glycolysis and glycolytic capacity in SW480
and DLD1 cells (Figures 2a–d). The glycolytic reserve was also
increased in PHLPP knockdown DLD1 cells (Figure 2d). In addition,
we found that PHLPP loss altered mitochondrial respiration as
determined using Seahorse Mito stress tests. The oxygen
consumption rates (OCR) associated with both basal and maximal
mitochondrial respiration were signiﬁcantly unregulated in PHLPP
knockdown SW480 and DLD1 cells (Supplementary Figure S1).
Furthermore, the bioenergetic measurement of relative utilization
of mitochondrial respiration versus glycolysis demonstrated that
knockdown of either PHLPP isoform enhanced the glycolytic
potential as well as the mitochondrial respiration in both cell lines
(Figures 2e and f), suggesting that increased glucose utilization
is accompanied by increased mitochondrial metabolism. Taken

Figure 1. Knockdown of PHLPP isoforms alters glucose utilization. (a) Stable control (sh-Con) and PHLPP knockdown (sh-PHLPP1 and
sh-PHLPP2) colon cancer cells, including SW480, DLD1 and Caco2, were analyzed for the phosphorylation and expression of Akt, PHLPP1 and
PHLPP2 using Western blotting. (b) The levels of glucose consumption and (c) lactate production were measured in culture medium collected
from control and PHLPP knockdown cells. Data represent the mean ± S.E.M. (n = 3, *P o0.05 as determined by two-sample t-tests compared
with the control cells).
Cell Death Discovery (2017) 16103
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Figure 2. PHLPP regulates glycolysis and mitochondrial respiration in colon cancer cells. (a) Representative ECAR measurements obtained
from the glycolysis stress test performed in control (sh-Con) and PHLPP knockdown (sh-PHLPP1 and sh-PHLPP2) SW480 cells using
the Seahorse XF96 Extracellular Flux analyzer (Agilent). Glucose, oligomycin and 2-deoxyglucose (2-DG) were added at the indicated points.
(b) Experiments as shown in (a) were quantiﬁed and ECAR associated with glycolysis, glycolytic capacity and glycolytic reserve was calculated
based on the measurements obtained upon the addition of individual compounds. Data represent the mean ± S.E.M. (n = 15, *P o0.05 as
determined by two-sample t-tests compared with the control cells). (c) Representative ECAR measurements obtained from the glycolysis stress
test performed in control (sh-Con) and PHLPP knockdown DLD1 cells. (d) Experiments and quantiﬁcation of the data were performed as
described above in (b). Data represent the mean ± S.E.M. (n = 15, *Po 0.05 as determined by two-sample t-tests compared with the control
cells). (e–f) Energetic maps of control and PHLPP knockdown SW480 (e) and DLD1 cells (f). Measurements of ECAR and OCR as described
above were quantiﬁed. The OCR and ECAR data shown in the map represent the OCR of basal respiration from the Mito stress test and the
glycolysis-related ECAR from the glycolysis stress test, respectively (data represent the mean ± S.E.M., n = 15).

together, these results demonstrate that downregulation of PHLPP
promotes the uptake of glucose followed by increased glycolysis
and mitochondrial respiration in colon cancer cells.
PHLPP controls Akt-mediated phosphorylation of HK2
Inhibition of mitochondrial respiration often leads to increased
glycolysis at the expense of oxidative phosphorylation. However,
Ofﬁcial journal of the Cell Death Differentiation Association

since downregualtion of PHLPP resulted in increased levels of
glycolysis and mitochondrial respiration rather than switching
cells from oxidative phosphorylation to glycolysis, we reasoned
that PHLPP likely targets a pivotal regulator of glycolysis directly.
HK2, a substrate of Akt, has been shown to promote tumor growth
via its ability to control glycolysis.21 Here we investigated whether
knockdown of PHLPP alters HK2 phosphorylation. To analyze Aktmediated phosphorylation of HK2, HK2 was immunoprecipitated
Cell Death Discovery (2017) 16103
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from control and PHLPP knockdown SW480 cells and Aktmediated phosphorylation of HK2 was detected using the
phospho-Akt-substrate antibody. Indeed, HK2 phosphorylation
was markedly increased in both PHLPP1 and PHLPP2 knockdown
cells, whereas the expression of total HK2 remained unchanged
(Figure 3a). Consistently, the phosphorylation of Akt was also
elevated in PHLPP knockdown cells indicating increased activation
(Figure 3a). Moreover, we found that Akt-mediated phosphorylation of HK2 was largely increased in PHLPP knockout mouse
embryonic ﬁbroblast (MEF) cells, which coincided with elevated
levels of glucose consumption and lactate production
(Supplementary Figure S2). Similar as in colon cancer cells,
Seahorse bioenergetic measurements showed that PHLPP knockout MEF cells have increased levels of glycolysis and mitochondrial
respiration (Supplementary Figure S2). Together, these results
suggest that PHLPP may regulate glycolysis by controlling the
phosphorylation of HK2.
Previous studies have shown that HK2 is phosphorylated by Akt
at T473 site.22 To further deﬁne the speciﬁcity of Akt-mediated
phosphorylation of HK2, we expressed wild-type (WT), and
phosphorylation mutants of HK2 (including the phosphorylationdeﬁcient T473A and phospho-mimetic T473D) in 293T cells and
analyzed the levels of phosphorylation using the phospho-Akt
substrate antibody. As shown in Figure 3b, the phosphorylation
was detected only in WT HK2 under the control condition,
whereas the phospho-Akt substrate antibody failed to recognize
both HK2 mutants and WT HK2 when treated with Akt inhibitor
(Akt-VIII), thus conﬁrming that HK2 is phosphorylated by Akt at the
T473 site in cells. Intriguingly, HK2 was found to interact with Akt
in a phosphorylation-dependent manner as both HK2 mutants
and dephosphorylated HK2 in Akt-VIII-treated cells did not coimmunoprecipitated with Akt (Figure 3b).
Furthermore, as PHLPP in known to interact with Akt as
well,24,25 we investigated if PHLPP, Akt and HK2 form a functional
complex. Results from co-immunoprecipitation experiments
showed that WT HK2 did not bind PHLPP by itself, whereas coexpression of Akt markedly increased the interaction between WT
HK2 and PHLPP in 293T cells (Figure 3c). Both HK2 mutants
interacted with Akt and PHLPP with much reduced afﬁnity
(Figure 3c). In addition, we analyzed the nature of the endogenous
PHLPP–Akt–HK2 complex in colon cancer cells. SW480 cells were
fractionated into the mitochondrial and cytosolic fractions and the
presence of PHLPP, Akt and HK2 were detected in both fractions
(Figure 3d). Despite that only a small percentage of total cellular
PHLPP, Akt and HK2 proteins were found localized to the
mitochondrial fraction, a PHLPP–Akt–HK2 protein complex was
readily detected in the mitochondria but not in the cytosol
(Figure 3d). Consistent with our ﬁnding that Akt inhibitor disrupts
the interaction between HK2 and Akt, the mitochondrial PHLPP–
Akt–HK2 complex was dissociated in cells treated with Akt
inhibitor (Figure 3e). However, as Akt activity is required for
maintaining PHLPP protein stability,31,32 we were unable to
determine if silencing Akt disrupts PHLPP–HK2 interaction directly
as Akt loss signiﬁcantly reduced the total expression of PHLPP.
Collectively, our results are consistent with the notion that Akt
functions as a bridge to facilitate the formation of PHLPP–Akt–HK2
complex and Akt-mediated phosphorylation of HK2 at T473
residue is required for its association with the complex.
PHLPP regulates mitochondrial localization of HK2
To determine if PHLPP expression regulates the cellular localization of HK2, control and PHLPP knockdown SW480 cells were
fractionated into the mitochondrial and cytosolic fractions. We
found that downregulation of PHLPP resulted in a signiﬁcant
increase in the amount of HK2 associated with the mitochondrial
fraction (Figures 4a and b). This is consistent with previous
reports that Akt-mediated phosphorylation of HK2 promotes its
Cell Death Discovery (2017) 16103

translocation to the mitochondria.13,22 Furthermore, the HK
activity associated with the mitochondrial fraction was signiﬁcantly increased in PHLPP knockdown cells when normalized to
the amount of total mitochondrial proteins (Figure 4c). However,
when normalizing to the amount of HK2 detected in the
mitochondria, the relative HK activity was not altered in PHLPP
knockdown cells (Figure 4d). As a control, the total HK activity in
PHLPP knockdown cells also remained unchanged (Figure 4e).
Taken together, our results suggest that PHLPP loss increases the
level of HK2 activity associated with the mitochondria by
promoting mitochondrial association of HK2 rather than directly
altering HK2 enzyme activity.

Overexpression of PHLPP inhibits glycolysis and HK
phosphorylation
To investigate the effect of PHLPP overexpression on cellular
metabolism, we generated stable SW480 cells overexpressing
PHLPP isoforms and examined the phosphorylation of HK2. In
contrast to PHLPP knockdown cells, the phosphorylation of HK2
was largely decreased in PHLPP overexpressing cells as detected
by the phospho-Akt substrate antibody (Figure 5a). Consistent
with previous reports,26,29 PHLPP overexpression also resulted in a
decrease in Akt phosphorylation (Figure 5a). Next, we measured
glucose consumption and lactate production in PHLPP overexpressing SW480 cells. Overexpression of either PHLPP isoform
signiﬁcantly decreased both glucose consumption and lactate
production indicating reduced glycolysis (Figures 5b and c).
Furthermore, Seahorse glycolysis stress tests revealed that PHLPP
overexpression signiﬁcantly decreased ECAR associated with
glycolysis, glycolytic capacity as well as glycolytic reserve
(Figures 5d and e). In addition, OCR associated with basal and
maximal mitochondrial respiration and ATP turnover were
signiﬁcantly inhibited in PHLPP overexpressing cells as indicated
by Seahorse Mito stress test (Supplementary Figure S3). Finally,
bioenergetic measurements showed that overexpression of either
PHLPP isoform inhibited both glycolysis and mitochondrial
respiration in colon cancer cells (Figure 5f). Taken together with
results obtained in PHLPP knockdown cells, we show that PHLPP
has an important role in regulating the balance of overall
bioenergetics in colon cancer.

HK2 regulates glucose metabolism in colon cancer cells
To determine the functional effect of HK2 on regulating glucose
metabolism directly, we created stable HK2 knockdown SW480
cells using two different shRNA targeting sequences, and knockdown of HK2 had no effect on HK1 expression (Figure 6a). The HK
activity was effectively decreased by ~ 40–50% in total cell lysates
and in mitochondrial fractions in the knockdown cells (Figures 6b
and c). Consequently, the levels of glucose consumption and
lactate production were signiﬁcantly reduced (Figures 6d and e).
Results from Seahorse metabolic measurements showed that
ECAR associated with glycolysis, glycolytic capacity and glycolytic
reserve were all signiﬁcantly decreased in HK2 knockdown cells
(Figures 6f and g). Similarly, OCR associated with basal and
maximal mitochondrial respiration were decreased as well
(Supplementary Figure S4). The bioenergetic measurements
revealed that knockdown of HK2 reduced the glycolytic potential
as well as mitochondrial respiration in colon cancer cells
(Figure 6h). These ﬁndings are reminiscent of results obtained in
PHLPP overexpressing cells (Figure 5), thus supporting the notion
that PHLPP regulates glucose metabolism by controlling HK2
activity.
Ofﬁcial journal of the Cell Death Differentiation Association
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Figure 3. PHLPP regulates HK2 phosphorylation by forming a complex with Akt and HK2. (a) Knockdown of PHLPP increases Akt-dependent
phosphorylation of HK2. Cell lysates prepared from control and PHLPP knockdown SW480 cells were immunoprecipitated using the HK2
antibody. The phosphorylation of immunoprecipitated HK2 was detected using the phospho-Akt substrate antibody. Cell lysates were probed
for the phosphorylation of Akt and the expression of Akt and PHLPP isoforms using Western blotting analysis. (b) 293 T cells transfected with
WT-, T473A- or T473D-mutant HK2 were lysed and immunoprecipitated with the HK2 antibody. The phosphorylation of HK2 and the presence
of endogenous Akt in the immunoprecipitates were detected using the phospho-Akt substrate and Akt antibodies, respectively. The
phosphorylation and expression of Akt, and the expression of HK2 and tubulin in the cell lysates were analyzed using Western blotting.
(c) 293 T cells transfected with HA-PHLPP1 together with WT-, T473A- or T473D-mutant HK2 and Flag-Akt were lysed and immunoprecipitated
with the HK2 antibody. The presence of PHLPP1, HK2 and Akt in the immunoprecipitates was detected using corresponding antibodies. The
expression of PHLPP, HK2, Akt and tubulin in the cell lysates were analyzed using Western blotting. (d–e) SW480 cells cultured under regular
growth condition (d) or treated with Akt-VIII for 16 h (e) were fractionated into the cytosolic (C) and mitochondrial (M) fractions and both
fractions were immunoprecipitated with either protein A/G agarose beads alone (mock) or the HK2 antibody. The amount of proteins from
each fraction in the input represent 10% of total lysates used for immunoprecipitation. The presence of PHLPP1, PHLPP2, HK2 and Akt in the
immunoprecipitates were detected using corresponding antibodies. ERK and COX4 were used as markers of cytosolic and mitochondrial
proteins, respectively.

Ofﬁcial journal of the Cell Death Differentiation Association
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Figure 4. Knockdown of PHLPP promotes mitochondrial association of HK2. (a) Control and PHLPP knockdown SW480 cells were fractionated
into cytosolic (C) and mitochondrial (M) fractions. The distribution of HK2 in each fraction was analyzed using Western blotting. ERK and COX4
were used as markers of cytosolic and mitochondrial proteins, respectively. (b) The relative expression of HK2 in the mitochondrial fraction
was quantiﬁed by normalizing to COX4 and compared with the control cells. Data represent mean ± S.E.M. (n = 5, #P o0.01 and *P o0.05 as
determined by two-sample t-tests compared with the control cells). (c) The HK activity was determined in the mitochondrial fraction of the
control and PHLPP knockdown SW480 cells. The activity was normalized to the amount of total proteins in the assay. Data represent mean ±
S.E.M. (n = 3, #P o0.01 and *P o0.05 as determined by two-sample t-tests compared with the control cells). (d) The HK activity was determined
in the mitochondrial fraction as described in (c). The mitochondrial protein lysates used for enzyme activity assays were analyzed by Western
blotting to determine the level of HK2 in each assay. The relative HK activity was obtained by normalizing to the amount of HK2 detected by
the HK2 antibody. Data represent mean ± S.E.M. No statistical difference was found among cell lines. (e) The HK activity was determined in the
whole-cell lysates of the control and PHLPP knockdown SW480 cells. The activity was normalized to the amount of total proteins in the assay.
Data represent mean ± S.E.M. No statistical difference was found among cell lines.

Inhibition of Akt or HK2 activity reverses PHLPP loss-induced
increase in glycolysis
As we found that knockdown of PHLPP increases mitochondrial
localization of HK2 by promoting Akt-dependent phosphorylation,
we next determined the effect of Akt inhibition on PHLPPmediated regulation of glycolysis. Stable control and PHLPP
knockdown SW480 cells were treated with Akt inhibitor and the
expression of HK2 in mitochondrial fractions was examined.
Similar as shown in Figure 4a, the amount of HK2 found in the
mitochondrial fraction was increased in PHLPP knockdown cells;
however, this increase in mitochondrial HK2 was effectively
blocked by treating cells with Akt-VIII (Figure 7a). Functionally,
this reduced mitochondrial localization of HK2 coincided with
changes in glucose consumption and lactate production, in which
Akt-VIII treatment inhibited glucose consumption and lactate
production in both control and PHLPP knockdown cells and
eliminated the increase in glycolysis induced by PHLPP loss
(Figures 7b and c). Moreover, we examined if dissociation of HK2
from the mitochondria affects PHLPP-mediated regulation of
glycolysis. Cells were treated with clotrimazole (CTZ), a previously
characterized HK2 inhibitor that functions by dissociating HK2
from mitochondria.13 CTZ treatment led to a signiﬁcant detachment of HK2 from the mitochondria in both control and PHLPP
knockdown SW480 cells (Figure 7d). As a consequence, the
increase in glucose consumption and lactate production observed
in PHLPP knockdown cells was eliminated (Figures 7e and f).
Collectively, our results indicate that inhibition of Akt activity or
Cell Death Discovery (2017) 16103

dissociation of HK2 from the mitochondria precludes cells from
responding to PHLPP downregulation.
Knockdown of HK2 attenuates the effect of PHLPP loss on
glycolysis
To further determine the functional contribution of HK2 downstream of PHLPP, HK2 expression was depleted in PHLPP
knockdown cells (Figure 8a). Consistent with results shown earlier,
knockdown of either PHLPP isoform signiﬁcantly increased,
whereas silencing HK2 expression decreased glucose consumption and lactate production in SW480 cells (Figures 8b and c).
Importantly, PHLPP loss-induced increase in glycolysis was
abolished in cells where HK2 was also knocked down
(Figures 8b and c), thus suggesting that HK2 functions downstream of PHLPP to regulate glycolysis.
Furthermore, we determined the functional implication of
PHLPP-mediated regulation of glucose metabolism in colon cancer
cells. Control and PHLPP knockdown cells were cultured in high- or
low-glucose medium for 48 h, and the relative cell survival was
determined by comparing the extent of cell growth under the lowglucose condition to that of the high-glucose condition. Interestingly, silencing PHLPP expression rendered both SW480 and Caco2
cells more sensitive to glucose restriction in that the relative cell
survival was signiﬁcantly decreased in PHLPP knockdown cells
when cultured under the low-glucose condition (Figures 8d and e).
Taken together, our data indicate that downregulation of
Ofﬁcial journal of the Cell Death Differentiation Association
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Figure 5. Overexpression of PHLPP inhibits glycolysis and mitochondrial respiration via dephosphorylation of HK2. (a) Stable control and
PHLPP overexpressing SW480 cells were analyzed for Akt-mediated HK2 phosphorylation. Cell lysates were immunoprecipitated using the
HK2 antibody. The phosphorylation of immunoprecipitated HK2 was detected using the phospho-Akt substrate antibody. The cell lysates
were probed for the phosphorylation of Akt and the expression of Akt and PHLPP isoforms using Western blot analysis. (b) The levels of
glucose consumption and (c) lactate production were measured in culture medium collected from control and PHLPP overexpressing cells.
Data represent the mean ± S.E.M. (n = 3, *Po0.05 as determined by two-sample t-tests compared with the control cells). (d) Representative
measurements obtained from the glycolysis stress test performed in control (vector) and PHLPP overexpressing cells using the Seahorse XF96
Extracellular Flux analyzer (Agilent). (e) Experiments as shown in (d) were quantiﬁed and ECAR associated with glycolysis, glycolytic capacity
and glycolytic reserve was calculated based on the measurements obtained upon the addition of individual compounds. Data represent the
mean ± S.E.M. (n = 15, *P o0.05 as determined by two-sample t-tests compared with the control cells). (f) A representative energetic map of
control and PHLPP overexpressing cells. The OCR and ECAR data shown in the map represent the OCR of basal respiration from the Mito stress
test and the glycolysis-related ECAR from the glycolysis stress test, respectively (data represent the mean ± S.E.M., n = 15).

PHLPP allows the cancer cells to preferentially utilize glucose as a
metabolic substrate to support cell growth and survival.
DISCUSSION
Cancer cells are rapidly dividing cells that have increased
demands for energy and macromolecules. To cope with these
elevated requirements cancer cells undergo major metabolic
modiﬁcations.2,33 Emerging evidence suggests that activated
Ofﬁcial journal of the Cell Death Differentiation Association

oncogenes and inactivated tumor suppressors may drive tumorigenesis by rewiring cellular metabolic pathways. Overall, metabolic reprogramming allows cancer cells to utilize limited amount
of nutrients available in the tumor microenvironment to overcome
metabolic stresses.2 Our study here has identiﬁed a novel role of
PHLPP in regulating cellular metabolism in colon cancer cells. We
show that loss of PHLPP expression promotes glycolysis and
mitochondrial respiration by upregulating Akt-dependent phosphorylation and mitochondrial translocation of HK2. Importantly,
Cell Death Discovery (2017) 16103
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Figure 6. Knockdown of HK2 inhibits glycolysis and mitochondrial respiration in colon cancer cells. (a) Stable control and two HK2 knockdown
(sh-HK2-1 and sh-HK2-2) SW480 cells were analyzed for HK2 and HK1 expression using Western blotting. (b) The HK activity was determined in
the whole-cell lysates and (c) the mitochondrial fraction of control and HK2 knockdown cells. Data represent mean ± S.E.M. (n = 3, *Po0.05 as
determined by two-sample t-tests compared with the control cells). (d) The levels of glucose consumption and (e) lactate production were
measured in culture medium collected from control and HK2 knockdown cells. Data represent the mean ± S.E.M. (n = 3, *Po0.05 as
determined by two-sample t-tests compared with the control cells). (f) Representative measurements obtained from the glycolysis stress test
performed in control and HK2 knockdown cells using the Seahorse XF96 Extracellular Flux analyzer (Agilent). (g) Experiments as shown in (f)
were quantiﬁed and ECAR associated with glycolysis, glycolytic capacity and glycolytic reserve was calculated based on the measurements
obtained upon the addition of individual compounds. Data represent the mean ± S.E.M. (n = 15, *Po 0.05 as determined by two-sample t-tests
compared with the control cells). (h) A representative energetic map of control and HK2 knockdown cells. The OCR and ECAR data shown in
the map represent the OCR of basal respiration from the Mito stress test and the glycolysis-related ECAR from the glycolysis stress test,
respectively (data represent the mean ± S.E.M., n = 15).

Cell Death Discovery (2017) 16103
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Figure 7. Inhibition of Akt activity or HK2 mitochondrial localization antagonizes PHLPP loss-induced increases in glycolysis. (a) Stable control
and PHLPP knockdown SW480 cells were treated with DMSO or Akt inhibitor VIII for 16 h in regular growth medium. Mitochondrial fractions
were prepared and analyzed for the levels of HK2 using Western blotting. COX4 was used as a marker for mitochondrial proteins. (b) The levels
of glucose consumption and (c) lactate production were measured in culture medium collected from the cells as treated in (a). Data represent
the mean ± S.E.M. (n = 3, *P o0.05 as determined by two-sample t-tests compared with control cells under basal condition). (d) Stable control
and PHLPP knockdown SW480 cells were treated with DMSO or CTZ for 16 h in regular growth medium. Mitochondrial fractions were
prepared and analyzed for the levels of HK2 using Western blotting. COX4 was used as a marker for mitochondrial proteins. (e) The levels of
glucose consumption and (f) lactate production were measured in culture medium collected from the cells as treated in (d). Data represent
the mean ± S.E.M. (n = 3, *P o0.05 as determined by two-sample t-tests compared with control cells under basal condition).

our ﬁndings that PHLPP loss induced upregulation of glycolysis
can be abolished by inhibition of Akt, dissociation of HK2 from the
mitochondria or knockdown of HK2 indicate that PHLPP regulates
glucose metabolism through a PHLPP/Akt/HK2 axis in colon
cancer cells.
Ofﬁcial journal of the Cell Death Differentiation Association

Previous studies have identiﬁed PHLPP as a tumor suppressor in
several types of cancer. Loss of PHLPP expression has been linked
to increased cell proliferation, decreased apoptosis and increased
ability of cancer cells to migrate and invade by inducing
epithelial–mesenchymal transition.24–26,28,29,34–37 Interestingly, it
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Figure 8. Knockdown of HK2 blocks PHLPP loss induced increases in glycolysis. (a) Stable control and PHLPP knockdown SW480 cells were
infected with shRNA lentiviruses targeting HK2 (sh-HK2-1). The expression of HK1, HK2 and PHLPP isoforms was detected using Western blot
analysis. (b) The levels of glucose consumption and (c) lactate production were measured in culture medium collected from the cells as
described in (a). Data represent the mean ± S.E.M. (n = 3, *P o0.05 as determined by two-sample t-tests compared with control cells). The
control and PHLPP knockdown SW480 (d) and Caco2 (e) cells were cultured in either the high-glucose or the low-glucose medium for 48 h.
The relative cell survival was determined by comparing the cell growth under the low-glucose condition with that of the high-glucose
condition. Data represent the mean ± S.E.M. (n = 6, *P o0.05 as determined by two-sample t-tests compared with the control cells).

has been shown that PHLPP inhibits protein synthesis by directly
dephosphorylating and inactivating S6K, a key regulator of protein
translation, and PHLPP loss increases the rate of cap-dependent
protein synthesis.27 This increased biomass synthesis is likely
coupled with heightened demands for ATP and metabolic
intermediates. We show in this study that PHLPP depletion allows
cancer cells to upregulate glucose metabolism and mitochondrial
respiration. The mitochondrial respiration is likely activated
because the mitochondria are responsible for further processing
the intermediate metabolites produced by the glycolytic pathway.
Overall, the metabolic alterations induced by PHLPP loss may
provide the necessary building blocks needed for growing cell
mass. In addition, consistent with our previous report that PHLPP
expression is signiﬁcantly downregulated under hypoxia,38 our
ﬁndings here suggest that PHLPP loss may contribute to altered
glucose metabolism in response to hypoxic stress in colon cancer.
Results from our study identify HK2 as a major effector of
PHLPP-mediated regulation of glycolysis. HK2 has been shown to
be the only HK isoform that is regulated by Akt-dependent protein
Cell Death Discovery (2017) 16103

phosphorylation.15,22 Phosphorylation of HK2 at T473 site
promotes mitochondrial binding of HK2, which facilitates the
coupling of glycolysis and oxidative phosphorylation through
preferential access of HK2 to ATP generated by mitochondria.39
Indeed, although the amount of HK2 localized in the mitochondrial fraction is o 5% of total HK2 expressed based on Western
blotting analysis, the HK activity associated with the mitochondria
is at least ﬁve times higher than that in the cytosol in SW480 cells
(data not shown). Thus, the mitochondria-localized HK2 may have
a functionally more important role. Using the phospho-Akt
substrate antibody and phosphorylation site mutations of HK2,
we demonstrate that PHLPP negatively regulates the phosphorylation of HK2 at T473 site and subsequently the mitochondrial
association of HK2. In our study, we also ﬁnd that puriﬁed
phosphatase domains of PHLPP can dephosphorylate HK2 directly
in vitro (data not shown) raising the possibility that PHLPP may
function as a phosphatase of HK2 in addition to its ability to
dephosphorylate Akt. However, as Akt is required for bringing
PHLPP to the PHLPP–Akt–HK2 complex at the mitochondria, we
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interpret our data as suggesting that PHLPP-mediated regulation
of HK2 phosphorylation likely occurs within the PHLPP–Akt–HK2
complex where PHLPP has a direct access to its substrate Akt, and
potentially HK2. Regardless of a direct or indirect mechanism of
action, our study identiﬁes a signaling complex that is consisted of
both a positive and a negative regulator of HK2 at the
mitochondria; and the formation of this localized complex may
allow for rapid adjustments of HK2 activity based on shifting
metabolic requirements.
It is intriguing that the HK2-T473D mutant fails to bind Akt
efﬁciently. It has been shown previously that the amount of
mitochondrial localization of HK2-T473D is similar as that of the
phosphorylated WT HK2.22 However, HK2 is known to localize to
the mitochondria by binding to voltage-dependent anion channel
on the outer membrane of mitochondria,13,15,40 where it may
also interact with Akt. It is possible that the T473D mutation allows
HK2 to bind voltage-dependent anion channel with higher afﬁnity
as it becomes more resistant to glucose-6-phosphate-induced
dissociation;22 however, the Glu substitution is not sufﬁcient to
mimic a phosphate group in mediating the interaction with Akt.
Future studies are needed to determine if the PHLPP–Akt–HK2
complex is anchored to the mitochondria via binding to voltagedependent anion channel.
In summary, results from our study provide strong evidence
suggesting that PHLPP has an important role in regulating
glucose metabolism by controlling Akt and HK2 function in colon
cancer cells. As PHLPP is lost in a majority of colon cancer
patients26,29 and PHLPP loss renders cancer cells sensitive to
glucose restriction-induced cell death, selectively targeting HK2
(such as using agents that dissociate HK2 from mitochondria) may
provide a novel treatment option for colon cancer patients.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies against PHLPP1 and PHLPP2 were purchased from Proteintech
(Rosemont, IL, USA) and Bethyl Laboratory (Montgomery, TX, USA),
respectively. The HK1, HK2, ERK, Akt, phosphor-Akt (Ser473) and
phospho-Akt-substrate (RXXS*/T*, 110B7E) antibodies were from Cell
Signaling. The HK2 (used for immunoprecipitation) and COX4 antibodies
were from Santa Cruz Biotechnology (Dallas, TX, USA). The expression
plasmids for HA-tagged PHLPP1 and PHLPP2 have been described in
previous studies.24,25,29,38 CTZ was obtained from Sigma-Aldrich (St Louis,
MO, USA) and used at 20 μM and Akt inhibitor VIII was from Millipore
(Billerica, MA, USA) and used at 1 μM for the treatment of cells. The coding
sequence of mouse HK2 was ampliﬁed using PCR and subcloned into
pcDNA4-Myc/His vector. Mutant HK2 expression plasmids including T473A
and T473D were generated using QuickChange site-directed mutagenesis
kit (Agilent, Santa Clara, CA, USA).

Cell culture
Human colon cancer cell lines, including SW480, DLD1 and Caco2, and 293 T
and MEF cells were cultured in DMEM supplemented with 10% fetal bovine
serum (FBS, Sigma-Aldrich) and 1% penicillin–streptomycin. Stable PHLPP and
HK2 knockdown cells were generated by lentivirus-based shRNAs as previously described.26,29,38 The shRNA targeting sequences for HK2 are as the
following: 5′-CCGTAACATTCTCATCGATTT-3′ (#1), and 5′-ACTGAGTTTGACC
AGGAGATT-3′ (#2). Overexpression of PHLPP isoforms in colon cancer
cells was achieved by infecting cells with retrovirus encoding HA-tagged
PHLPP1 or PHLPP2 and selecting with puromycin. MEF cells were isolated
from WT, Phlpp1–/– or Phlpp2–/– mouse embryos at day 14 of gestation and
immortalized by knocking down p53 expression.26,41 Transient transfection of
293T cells with the expression plasmids encoding HA-tagged PHLPP1 and
PHLPP2 was carried out using PEI-mediated method.

Immunoprecipitation and Western blot analysis
Cells were washed in ice-cold PBS three times and lysed with lysis buffer
(50 mM Na2HPO4, pH 7.4, 1 mM sodium pyrophosphate, 20 mM NaF, 2 mM
EDTA, 2 mM EGTA, 1% Triton X-100, 1 mM DTT, 200 mM benzamidine,
Ofﬁcial journal of the Cell Death Differentiation Association

40 mg/ml leupeptin, 200 mM PMSF) and the detergent-solublized cell
lysates were obtained after centrifugation for 5 min at 16 000 × g at
4 °C.26,29,38 Equal amounts of solublized cell lysates were resolved by SDSPAGE and subjected to Western blot analysis. To examine the phosphorylation status of HK2 and the interaction between HK2 and PHLPP, the
solublized cell lysates were incubated with the HK2 antibody and protein
A/G agarose beads (Pierce) at 4 °C for overnight. The beads were washed
three times with lysis buffer and the immunoprecipitated proteins were
analyzed by SDS-PAGE and Western blotting.

Mitochondrial fractionation
Cells washed with ice-cold PBS were lysed in mitochondrial lysis buffer
(250 mM sucrose, 20 mM HEPES, pH 7.4, 20 mM NaF, 10 mM KCl,
1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 200 mM benzamidine,
40 mg/ml leupeptin and 200 mM PMSF). After brief sonication, samples
were centrifuged at 1000 × g for 10 min at 4 °C to remove cell debris and
nuclei. The supernatant was subsequently centrifuged again at 13 000 × g
for 20 min at 4 °C and the resulting supernatant was saved as the cytosol
fraction. The pellet was washed twice with mitochondrial lysis buffer,
dissolved in lysis buffer and saved as the mitochondria fraction. The
mitochondria and cytosol fractions were resolved by SDS-PAGE and
subjected to Western blot analysis. Separation of COX4 and ERK into the
mitochondria and cytosol fraction, respectively, was used as the control for
the fractionation experiments.

Measurements of glucose consumption and lactate production
Cells were seeded in six-well plate at the density of 5 × 105 cells per well in
1 ml DMEM growth medium. A blank well without cells was included as the
control. After 16 h incubation, glucose and lactate concentrations in the
culture medium were measured using the Glucose Assay Kit and L-Lactate
Assay Kit (Biovison, Milpitas, CA, USA), respectively. The levels of glucose
consumption and lactate production were determined by subtracting the
concentration of glucose or lactate in the control medium from that in the
sample medium. The numbers of cells in each well were counted and used
for normalizing the data.

Hexokinase activity assay
The HK activity was determined using the Hexokinase Assay Kit per
manufacturer’s protocol (Biomedical Research Service Center, SUNY,
Buffalo, NY, USA). Brieﬂy, 1 × 106 cells washed in ice-cold PBS were
resuspended in 100 μl of HK cell lysis solution. The cell lysates were
centrifuged for 3 min at 13 000 × g at 4 °C and the resulting supernatant
was used in the HK activity assay. In experiments where the mitochondrial
HK activity was measured, cells were ﬁrst fractionated into mitochondria
and cytosol fractions and only the mitochondria fraction was used in the
HK activity assay. The reactions were carried out in 96-well plates at 37 °C
for 1 h and the HK activity (expressed as IU/l) was calculated based on the
absorbance at OD492 and normalized to the amount of proteins in each
sample or to the levels of HK2 as detected by Western blotting.

Seahorse extracellular ﬂux analysis
The Seahorse XF96 Extracellular Flux Analyzer (Agilent) was used to
measure cellular respiration activity in colon cancer cells. Cells were
seeded at the density of 3 × 104 cells per well in a XF96 plate ~ 12 h
before the measurement. The glycolysis and mitochondrial stress test
were performed per manufacturer’s protocol. The relative levels of nonglycolytic acidiﬁcation, glycolysis, glycolytic capacity and glycolytic reserve
were calculated based on OCR and ECAR data obtained in the glycolysis
stress tests, whereas the relative levels of non-mitochondrial, basal,
maximal and ATP production-related respiration were calculated based on
the Mito stress tests using Seahorse Wave software (Agilent) for XF
analyzers.

Cell viability assay
Equal numbers of control and PHLPP knockdown cells (20 000 cells per
well) were seeded onto 24-well plates and cultured overnight in regular
growth medium (DMEM containing 4.5 g/l glucose plus 10% FBS). Cells
were then switched to low-glucose growth medium (DMEM containing
1 g/l glucose plus 10% FBS) or maintained in regular growth medium for
additional 48 h. At the end of the experiments, the cells were ﬁxed and
stained with 0.5% crystal violet in 20% methanol for 30 min. After washing
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with water, the stained cells were dissolved in 1% SDS and absorbance at
OD570 was measured.29 The relative cell survival was calculated by
comparing the OD570 values obtained under the low-glucose condition
with those of the regular growth medium.
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